State authorities on Tuesday accused a subsidiary of New Jersey pharmaceutical giant Johnson & Johnson of using "deceptive marketing" to boost profits by playing down the risks of highly-addictive painkillers.

In a lengthy lawsuit filed in state Superior Court, New Jersey's attorney general contended Janssen Pharmaceuticals, Inc. violated the state's Consumer Fraud Act and fueled the opioid addiction crisis.